| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.581 | 31.754 | 35.896 | 29.101 | 30.636 | 27.930 | 27.040 | 25.415 | 7.930 | 0 |
| Total Income - EUR | 14.581 | 31.754 | 35.896 | 29.101 | 30.636 | 27.930 | 27.040 | 25.415 | 7.930 | 0 |
| Total Expenses - EUR | 9.916 | 16.022 | 25.401 | 14.452 | 29.793 | 28.331 | 30.207 | 19.608 | 19.121 | 1.245 |
| Gross Profit/Loss - EUR | 4.665 | 15.732 | 10.495 | 14.649 | 844 | -400 | -3.166 | 5.807 | -11.191 | -1.245 |
| Net Profit/Loss - EUR | 4.228 | 15.025 | 10.136 | 14.082 | 371 | -680 | -3.432 | 5.558 | -11.270 | -1.245 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Echobina Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.012 | 951 | 784 | 621 | 7.186 | 6.287 | 5.402 | 6.709 | 6.149 | 5.578 |
| Current Assets | 10.238 | 19.110 | 34.232 | 52.286 | 53.404 | 51.840 | 51.548 | 68.649 | 67.027 | 66.652 |
| Inventories | 1.770 | 1.939 | 2.374 | 2.330 | 2.285 | 2.242 | 2.192 | 2.552 | 352 | 350 |
| Receivables | 5.720 | 11.633 | 31.604 | 49.288 | 47.464 | 47.295 | 48.778 | 63.184 | 66.062 | 65.692 |
| Cash | 2.748 | 5.538 | 255 | 668 | 3.655 | 2.304 | 579 | 2.913 | 614 | 610 |
| Shareholders Funds | 3.878 | 18.863 | 28.680 | 42.235 | 36.831 | 35.452 | 31.235 | 36.890 | 25.507 | 24.119 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 7.372 | 1.198 | 6.336 | 10.672 | 24.645 | 23.543 | 26.565 | 39.319 | 48.518 | 48.956 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Echobina Med S.r.l.